Dudediligence.

PMGC Holdings Inc

ELABNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

6.15M

on 2026-06-30, from 516 on 2024-03-31 10-Q ↗

Earlier counts are adjusted for three reverse splits; each bar's tip shows the count as filed.

a raise that quarter, at its price

2M4M6M1:200 split1:7 split1:24 splitMar2024JunSepDecMar2025$5.04JunSepDecMar2026Jun

Newest

$100.0M

S-3 of 2025-01-27. 5 prospectus supplements filed under it since. S-3 ↗

$1.7M

Univest Securities, agreement of 2025-04-24. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

6

Warrants of every class as tagged in the XBRL facts on 2026-06-30, exercise price $275582.86. 10-Q ↗

Cash

9.2 quarters

$18.8M on 2026-06-30 ÷ $2.1M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-04-20Public offeringnot readnot readnot read424B5 ↗
2026-04-01Public offeringnot readnot readnot read424B5 ↗
2026-02-17Public offeringnot readnot readnot read424B5 ↗
2026-01-12Public offeringnot readnot readnot read424B5 ↗
2025-03-21Public offering incl. 0.17M pre-funded294,450$5.04$1.5M424B5 ↗
2025-03-21Registered direct offering incl. 0.17M pre-funded330,610not readnot read8-K ↗

Also on file: a 1-for-200 reverse split, 2024-11-20 8-K ↗ · a 1-for-7 reverse split, 2025-03-10 8-K ↗ · a 1-for-6 reverse split, 2026-03-10 8-K ↗ · a 1-for-10 reverse split, 2026-08-21 8-K ↗